ALOMIDE (Alcon Laboratories, Inc.)


Welcome to the PulseAid listing for the ALOMIDE drug offered from Alcon Laboratories, Inc.. This Decreased Histamine Release [PE],Mast Cell Stabilizer [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Alcon Laboratories, Inc.
NON-PROPRIETARY NAME: lodoxamide tromethamine
SUBSTANCE NAME: LODOXAMIDE TROMETHAMINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Histamine Release [PE],Mast Cell Stabilizer [EPC]
ROUTE: OPHTHALMIC
DOSAGE FORM: SOLUTION/ DROPS
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1993-09-30
END MARKETING DATE: 0000-00-00


ALOMIDE HUMAN PRESCRIPTION DRUG Details:

Item DescriptionALOMIDE from Alcon Laboratories, Inc.
LABELER NAME: Alcon Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/mL)
START MARKETING DATE: 1993-09-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0065-0345_39e9bbd1-8e0c-596f-710e-4d0cde8d8071
PRODUCT NDC: 0065-0345
APPLICATION NUMBER: NDA020191

Other LODOXAMIDE TROMETHAMINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alcon Laboratories, Inc.ALOMIDE